Mobile lifestyle app to prevent heart disease in high-risk urban office workers in Karachi

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests a context-specific mHealth app, m-LIfE, aimed at increasing physical activity and improving diet among high-risk urban office workers in Karachi. Participants are bank employees with at least 6 months of experience, randomized to use the app for 12 weeks or receive routine printed prevention materials. The app provides reminders and tips to take breaks, exercise, and choose healthier foods. The trial will assess changes in lifestyle behaviors related to cardiovascular risk factors in a real-world workplace setting. Primary care and cardiology stakeholders in Pakistan collaborate with Aga Khan University and the Fogarty Center to explore scalable prevention strategies in LMICs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

• At least 6 months of job experience in any bank

Exclusion Criteria:

* Diagnosed case of myocardial infarction, stroke, coronary heart disease, cerebrovascular disease, or peripheral arterial diseases
* Pregnant women
* Individuals with acute illnesses that limit physical activity

Where it's running

• Aga Khan University
  Karachi, Sindh, Pakistan Recruiting

Study contacts

• Principal investigator: Aysha Almas, PhD — Aga Khan University
• Study coordinator: Samina Akhtar
• Email: samina.yousanaf@aku.edu
• Phone: +923314312920

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.